REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

TaiwanJ Pharmaceuticals Co., Ltd. (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: TaiwanJ Pharmaceuticals Co., Ltd. Profile Updated: July 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

TaiwanJ Pharmaceuticals Co., Ltd. is mainly into new drug research and development company. The company is mainly engaged in the treatment of chronic inflammation related diseases, including: diseases such as C or B hepatitis virus infection. TaiwanJ Pharmaceuticals was established in 2011 and located in Hsinchu County.

Headquarters
Rm.4,3F, No.6-1, Sec. 2, Shengyi Rd
Zhubei City;

Contact Details: Purchase the TaiwanJ Pharmaceuticals Co., Ltd. report to view the information.

Website: http://www.taiwanj.com

Basic Information
Total Employees:
Purchase the TaiwanJ Pharmaceuticals Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the TaiwanJ Pharmaceuticals Co., Ltd. report to view the information.
Financial Auditors:
Purchase the TaiwanJ Pharmaceuticals Co., Ltd. report to view the information.
Incorporation Date:
May 02, 2011
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
3.99%
Purchase this report to view the information.
2.58%
Purchase this report to view the information.
1.68%
Purchase this report to view the information.
0.15%
Purchase this report to view the information.
Subsidiaries
.90
0.9%
Company Performance
Financial values in the chart are available after TaiwanJ Pharmaceuticals Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
-29.7%▼
Total equity
-31.98%▼
Return on Equity (ROE)
N/A
Quick Ratio
-11.1%▼
Cash Ratio
-14.28%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo